Coronavirus SARS-CoV-2 vaccine: cerebral vein thrombosis (CVT)
Evidence-based neurology checklist on coronavirus sars-cov-2 vaccine: cerebral vein thrombosis (cvt): Pathology This is usually caused by vaccine-induced immune thrombotic thrombocytopaenia (VITT) There is triggered by the binding of adenoviral DNA with platelet factor 4 (PF4) This leads to the…
Pathology
- This is usually caused by vaccine-induced immune thrombotic thrombocytopaenia (VITT)
- There is triggered by the binding of adenoviral DNA with platelet factor 4 (PF4)
- This leads to the production of anti PF4 antibodies
- About 25% of cases however do not have VITT
- Those with VITT are younger and more likely to have multiple vein involvement
Epidemiological features
Clinical features
Haematological investigations
Brain imaging
Treatment: anticoagulation
Treatment: immunomodulation
Prognosis
Synonym of VITT
Acronym
References
- Furie KL, Cushman M, Elkind MSV, et al. Diagnosis and management of cerebral venous sinus thrombosis with vaccine-induced immune thrombotic thrombocytopenia. Stroke 2021; 52:2478-2482.
- Sánchez van Kammen M, Aguiar de Sousa D, Poli S, Cordonnier C, et al. Characteristics and outcomes of patients with cerebral venous sinus thrombosis in SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia. JAMA Neurol 2021 (Online ahead of print).
- Sharifian-Dorche M, Bahmanyar M, Sharifian-Dorche A, Mohammadi P, Nomovi M, Mowla A. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. J Neurol Sci 2021; 428:117607.
- Thakur KT, Tamborska A, Wood GK, et al. Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: evaluation, management, and scientific questions. J Neurol Sci 2021; 427:117532.
- Perry RJ, Tamborska A, Singh B, et al. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. Lancet 2021; 398:1147-1156.
- And 10 more. Subscribe to see the full list
Related checklists
- Coronavirus SARS-CoV-2 infection: epidemiology and prognosis
- Coronavirus SARS-CoV-2 infection: systemic features
- Coronavirus SARS-CoV-2 infection: central vascular features
- Coronavirus SARS-CoV-2 infection: central non-vascular features
- Coronavirus SARS-CoV-2 infection: cranial nerve disorders
- Coronavirus SARS-CoV-2 infection: peripheral features
- Coronavirus SARS-CoV-2 infection: neurological investigations
- Coronavirus SARS-CoV-2 infection: systemic investigations
- Coronavirus SARS-CoV-2 infection: treatments
- Coronavirus SARS-CoV-2 infection: high risk conditions
- Coronavirus SARS-CoV-2 infection: neurological disorders recommendations
- Coronavirus SARS-CoV-2 infection: multiple sclerosis (MS) recommendations
- Coronavirus SARS-CoV-2 vaccine: other neurological complications
- Coronavirus SARS-CoV-2 vaccine systemic complications
- Coronavirus SARS-CoV-2 infection: long COVID